ROYAL BANK OF CANADA - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$49,000
+145.0%
12,819
+106.1%
0.00%
Q2 2023$20,0006,221
+10814.0%
0.00%
Q1 2023$057
+1.8%
0.00%
Q4 2022$0
-100.0%
56
-87.8%
0.00%
Q3 2022$1,000
-66.7%
459
-52.2%
0.00%
Q1 2022$3,000
-40.0%
960
-36.0%
0.00%
Q4 2021$5,000
-80.0%
1,500
-80.0%
0.00%
Q3 2021$25,000
-74.2%
7,500
-69.7%
0.00%
Q2 2021$97,000
-67.8%
24,721
-67.0%
0.00%
Q1 2021$301,000
+58.4%
74,822
-9.1%
0.00%
Q4 2020$190,000
-92.1%
82,301
-80.4%
0.00%
-100.0%
Q3 2020$2,408,000
+171.2%
419,591
+248.2%
0.00%
Q2 2020$888,000
+4128.6%
120,490
+1591.3%
0.00%
Q1 2020$21,000
-25.0%
7,124
+6.8%
0.00%
Q4 2019$28,000
+154.5%
6,670
+98.7%
0.00%
Q3 2019$11,000
+37.5%
3,356
-19.2%
0.00%
Q2 2019$8,000
+100.0%
4,155
+92.8%
0.00%
Q1 2019$4,000
-20.0%
2,155
-2.4%
0.00%
Q4 2018$5,000
-64.3%
2,209
-11.1%
0.00%
Q3 2018$14,000
-12.5%
2,486
+28.0%
0.00%
Q2 2018$16,000
-20.0%
1,942
-30.4%
0.00%
Q1 2018$20,000
+566.7%
2,792
+748.6%
0.00%
Q3 2017$3,000329
+5383.3%
0.00%
Q2 2017$060.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders